Ian J Barrett, MD
Orthopedic Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 10 carriers
- Offices
- 2
Offices
2 locations · Advanced Surgical Associates · 6 clinicians in this group
Hospitals listed: 059461 · El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
36 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barrett’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A147622 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$165,994
Medicare paid this office $165,994 for 390 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 188 | $32,634 | $119 |
| New patient visit (45+ min) | 196 | $28,718 | $147 |
| Short return visit (20+ min) | 123 | $18,719 | $88 |
| Aspiration and/or injection of fluid from large joint | 140 | $16,306 | $70 |
| Replacement of knee joint, both sides of knee | 11 | $15,360 | $1,182 |
See all 10 services
| Return visit (30+ min) | 188 | $32,634 | $119 |
| New patient visit (45+ min) | 196 | $28,718 | $147 |
| Short return visit (20+ min) | 123 | $18,719 | $88 |
| Aspiration and/or injection of fluid from large joint | 140 | $16,306 | $70 |
| Replacement of knee joint, both sides of knee | 11 | $15,360 | $1,182 |
| Prosthetic repair of shoulder joint, total shoulder | 11 | $14,822 | $1,347 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 18 | $7,082 | None |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,440 | $76 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 111 | $1,091 | None |
| Aspiration and/or injection of fluid from medium joint | 12 | $657 | $51 |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 16 | More than 46% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 20 | More than 92% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
390 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 16% · Women 65% · Also on Medicaid 26% · Health risk score 1.15. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 27% · Depression 20% · Chronic kidney disease 19% · Atrial fibrillation 18% · Heart failure 16% · Cancer 15% · COPD 11% · Dementia 8% · Stroke 8%.
The office billed $1,727,982, Medicare allowed $213,339 and paid $165,994; for 2,542 services of 49 kinds; $8,175 of it was for drugs given in the office and $157,819 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 390 | 2,542 | 77 | 1.15 | $1,727,982 | $165,994 |
| 2023 | 399 | 2,879 | 77 | 1.10 | $2,144,871 | $199,986 |
| 2022 | 358 | 2,478 | 77 | 1.14 | $1,809,193 | $163,312 |
| 2021 | 286 | 1,528 | 77 | 1.13 | $1,662,241 | $161,508 |
| 2020 | 214 | 810 | 76 | 1.30 | $761,705 | $87,926 |
| 2019 | 179 | 597 | 76 | 1.22 | $402,077 | $75,019 |
| 2018 | 31 | 53 | 77 | 1.36 | $36,615 | $8,747 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 172 | $32,849 | $114 |
| New patient visit (45+ min) | 211 | $30,487 | $144 |
| Prosthetic repair of shoulder joint, total shoulder | 16 | $22,261 | $1,309 |
| Short return visit (20+ min) | 148 | $21,111 | $85 |
| Replacement of knee joint, both sides of knee | 13 | $15,784 | $1,127 |
| Aspiration and/or injection of fluid from large joint | 120 | $14,380 | $67 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 23 | $7,899 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,921 | $117 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 111 | $977 | None |
| Aspiration and/or injection of fluid from medium joint | 14 | $955 | $48 |
2022: 8 services
| New patient visit (45+ min) | 191 | $28,633 | $150 |
| Return visit (30+ min) | 129 | $24,975 | $116 |
| Short return visit (20+ min) | 152 | $20,499 | $81 |
| Treatment of broken neck of thigh bone with bone implant | 13 | $14,882 | $1,145 |
| Aspiration and/or injection of fluid from large joint | 88 | $9,604 | $59 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 11 | $7,490 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $5,024 | $123 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 73 | $680 | None |
2021: 8 services
| New patient visit (45+ min) | 169 | $24,911 | $147 |
| Return visit (30+ min) | 110 | $20,267 | $116 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 14 | $18,250 | None |
| Short return visit (20+ min) | 118 | $15,822 | $85 |
| Aspiration and/or injection of fluid from large joint | 70 | $7,020 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,100 | $124 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,762 | $98 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $505 | None |
2020: 7 services
| New patient visit (45+ min) | 123 | $17,481 | $142 |
| Return visit (30+ min) | 78 | $11,641 | $99 |
| Short return visit (20+ min) | 69 | $6,392 | $67 |
| Aspiration and/or injection of fluid from large joint | 45 | $3,871 | $55 |
| Measurement of range of motion in arm, leg or each spine section | 23 | $817 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $113 | None |
| Injection, triamcinolone acetonide, preservative free, 1 mg | 17 | $58 | None |
2019: 8 services
| Short return visit (20+ min) | 86 | $11,603 | $72 |
| New patient visit (45+ min) | 57 | $8,720 | $153 |
| Return visit (30+ min) | 43 | $6,364 | $104 |
| New patient visit (30+ min) | 61 | $6,242 | $102 |
| Repair of hip joint capsule | 11 | $5,596 | $509 |
| Aspiration and/or injection of fluid from large joint | 31 | $3,034 | $55 |
| Measurement of range of motion in arm, leg or each spine section | 28 | $1,288 | $21 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $106 | None |
2018: 1 service
| New patient visit (30+ min) | 24 | $2,439 | $102 |
Medicaid work
$6,234 in 2024
Medicaid paid $6,234 for 669 billed services this clinician did in 2024, up to 41 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 363 | $3,138 |
| New patient visit (45+ min) | 202 | $2,757 |
| Arthrocentesis and injection of knee joint | 104 | $339 |
| 2024 | 669 | 3 | 41 | $6,234 |
| 2023 | 597 | 2 | 41 | $2,534 |
| 2022 | 420 | 2 | 29 | $880 |
| 2021 | 400 | 2 | 29 | $2,170 |
| 2020 | 13 | 1 | 12 | $96 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 232 | $1,729 |
| Return visit (30+ min) | 365 | $804 |
2022
| Return visit (30+ min) | 236 | $476 |
| New patient visit (45+ min) | 184 | $405 |
2021
| New patient visit (45+ min) | 169 | $1,288 |
| Return visit (30+ min) | 231 | $882 |
2020
| Return visit (30+ min) | 13 | $96 |
Drugs they prescribed that Part D paid
$3,904
Pharmacies billed $3,904 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (132 of 465) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
465 generic and 0 brand-name prescriptions · $3,904 in drug cost · 16 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 102 | $1,277 | $13 |
| Gabapentin | 81 | $601 | $7 |
| Hydrocodone-Acetaminophen | 59 | $388 | $7 |
| Meloxicam | 47 | $300 | $6 |
| Diclofenac | 13 | $256 | $20 |
See all 8 drugs
| Celecoxib | 102 | $1,277 | $13 |
| Gabapentin | 81 | $601 | $7 |
| Hydrocodone-Acetaminophen | 59 | $388 | $7 |
| Meloxicam | 47 | $300 | $6 |
| Diclofenac | 13 | $256 | $20 |
| Tramadol | 62 | $170 | $3 |
| Naproxen | 29 | $92 | $3 |
| Ibuprofen | 22 | $86 | $4 |
Year by year
| 2024 | 465 | 148 | 28% (132) | 0% | $3,904 |
| 2023 | 422 | 134 | 33% (139) | None | $4,079 |
| 2022 | 303 | 95 | 29% (87) | 0% | $3,901 |
| 2021 | 285 | 84 | 28% (80) | None | $5,147 |
| 2020 | 231 | 77 | 26% (61) | None | $2,854 |
| 2019 | 115 | 41 | 22% (25) | None | $2,946 |
| 2017 | 61 | 32 | 66% (40) | None | $1,494 |
| 2016 | 57 | 40 | 61% (35) | None | $1,203 |
| 2015 | 43 | 28 | 65% (28) | None | $591 |
| 2014 | 215 | 76 | 50% (107) | None | $4,640 |
| 2013 | 31 | 15 | 65% (20) | None | $916 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Celecoxib | 64 | $879 | $14 |
| Gabapentin | 84 | $607 | $7 |
| Diclofenac | 18 | $520 | $29 |
| Hydrocodone-Acetaminophen | 69 | $422 | $6 |
| Meloxicam | 45 | $355 | $8 |
| Naproxen | 26 | $193 | $7 |
| Tramadol | 68 | $180 | $3 |
| Ibuprofen | 18 | $81 | $4 |
2022: 7 drugs
| Diclofenac | 27 | $1,116 | $41 |
| Celecoxib | 52 | $815 | $16 |
| Meloxicam | 45 | $504 | $11 |
| Gabapentin | 58 | $465 | $8 |
| Hydrocodone-Acetaminophen | 47 | $274 | $6 |
| Tramadol | 39 | $105 | $3 |
| Ibuprofen | 11 | $50 | $5 |
2021: 6 drugs
| Diclofenac | 35 | $1,835 | $52 |
| Gabapentin | 60 | $498 | $8 |
| Celecoxib | 36 | $423 | $12 |
| Hydrocodone-Acetaminophen | 46 | $311 | $7 |
| Meloxicam | 32 | $234 | $7 |
| Tramadol | 33 | $66 | $2 |
2020: 6 drugs
| Diclofenac | 24 | $1,112 | $46 |
| Gabapentin | 47 | $324 | $7 |
| Meloxicam | 45 | $292 | $6 |
| Celecoxib | 28 | $251 | $9 |
| Hydrocodone-Acetaminophen | 30 | $162 | $5 |
| Tramadol | 26 | $47 | $2 |
2019: 3 drugs
| Meloxicam | 40 | $236 | $6 |
| Gabapentin | 16 | $236 | $15 |
| Hydrocodone-Acetaminophen | 14 | $87 | $6 |
2017: 2 drugs
| Oxycodone | 17 | $193 | $11 |
| Tramadol | 17 | $80 | $5 |
2016: 1 drug
| Oxycodone | 26 | $242 | $9 |
2014: 3 drugs
| Oxycodone | 47 | $632 | $13 |
| Tramadol | 53 | $356 | $7 |
| Omeprazole | 13 | $137 | $11 |
2013: 1 drug
| Tramadol | 11 | $64 | $6 |
Money from drug and device companies
$106 in 2025
| 2025 | 4 | 5 | None | $106 |
| 2023 | 3 | 3 | None | $46 |
| 2022 | 3 | 6 | None | $1,310 |
| 2021 | 1 | 1 | None | $20 |
| 2020 | 3 | 3 | None | $70 |
| 2019 | 7 | 15 | None | $1,301 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Avanos Medical | On-Q Pump and Accessories | $42 | 2 payments
|
| Pacira Pharmaceuticals | Exparel | $31 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $18 | 1 payment
|
| Orthofix Medical | Physio-Stim | $15 | 1 payment
|
See all 5 published payments
| Avanos Medical | Meals · 2025-12-17 | On-Q Pump and Accessories | $22 |
| Orthofix Medical | Meals · 2025-11-06 | Physio-Stim | $15 |
| Avanos Medical | Meals · 2025-08-27 | On-Q Pump and Accessories | $20 |
| Pacira Pharmaceuticals | Meals · 2025-08-12 | Exparel | $31 |
| Vertex Pharmaceuticals | Meals · 2025-06-26 | Journavx | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $46
| SPR Therapeutics | Sprint Pns System | $17 | 1 payment
|
| Evolution Surgical | None | $15 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $13 | 1 payment
|
2022: $1,310
| Evolution Surgical | None | $1,229 | 2 payments
|
| Ethicon US | Stratafix | $59 | 3 payments
|
| Kowa Pharmaceuticals America | Seglentis | $22 | 1 payment
|
2021: $20
| Ethicon US | Stratafix | $20 | 1 payment
|
2020: $70
| DePuy Synthes Sales | Vapr | $33 | 1 payment
|
| Ermi | None | $22 | 1 payment
|
| Smith+Nephew | Santyl | $14 | 1 payment
|
2019: $1,301
| Medical Device Business Services | Milagro | $634 | 5 payments
|
| DePuy Synthes Sales | VA-Lcp Plates & Screws | $180 | 3 payments
|
| Smith+Nephew | Regeneten | $149 | 2 payments
|
| Pacira Pharmaceuticals | Exparel | $142 | 2 payments
|
| Zimmer Biomet Holdings | Accufill | $134 | 1 payment
|
| Stryker | Adapt | $40 | 1 payment
|
| Bioventus | Exogen | $21 | 1 payment
|
Checkups this office reported
19 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 97%That's most of the people this applied to. | 636 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 59%That's more than half. | 165 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 1%That's few of the people this applied to. Better on this measure. | 120 |
| Breast cancer screeningEligible women who got a mammogram | 29%That's less than half. | 298 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 30%That's less than half. | 272 |
| Checked for fall riskOlder patients screened for fall risk | 68%That's more than half. | 487 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 0% | 708 |
| Colon cancer screeningEligible adults who got a colon cancer test | 23%That's few of the people this applied to. | 624 |
See the other 11 measures
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 56%That's more than half. | 1,104 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 9%That's few of the people this applied to. | 45 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 53%That's more than half. Worse on this measure. | 45 |
| HIV screeningEligible patients who were screened for HIV | 13%That's few of the people this applied to. | 721 |
| Medications listed in the chartVisits where the current medication list was documented | 83%That's most of the people this applied to. | 2,330 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 449 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 111 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 12%That's few of the people this applied to. Better on this measure. | 511 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 14% | 1,940 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 85%That's most of the people this applied to. | 208 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 41%That's less than half. | 1,161 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Improved the patient portal
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Reports cases to public health electronically
- Reports immunizations to the state registry
Professional record
- NPI
- 1265794754
- Licence
- CA A147622California A147622: Current · expires 2027-01-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 555 Knowles Drive Suite 200, Los Gatos, CA, 95032
- NPI first listed
- 2012-06-12
- NPI last updated
- 2023-04-11
- NPI record certified
- 2023-04-11
This is when the NPI record was last certified, not a medical board exam.